recombinant FVIIa concentrate

recombinant FVIIa concentrate

a concentrate of activated factor VII developed to treat bleeding in hemophilia patients with inhibitors. Activated factor VII acts directly on factor X and bypasses VIII or IX activity in the coagulation process.
References in periodicals archive ?
It should be kept in mind that the cost of recombinant FVIIa concentrates is high and they carry a risk of thrombosis.
Full browser ?